DermatologyTimes - Dermatologic News and research spanning clinical, cosmetic specialties

ADVERTISEMENT

Previous StoryPlay / PauseNext Story
Web Exclusive
Camp Wonder opens derms’ eyes
Dermatologists helped to launch and volunteer at Camp Wonder, an annual week-long camp for children with severe skin disease.
In the Know

Given the vast amount of misinformation presented in the consumer media regarding cosmetic treatments, In The Know presents patients with information grounded in medicine and coming from the real experts. We talk with dermatologists and cosmetic surgeons on topics ranging from rosacea and acne, to fillers, lasers and facelifts. We hope the topics educate patients, inspire them to ask questions, and maybe even spur them to try a procedure.
To read our content, click here.

Beauty for a Lifetime
Research Briefs
Outdoor workers least likely to get skin exams
May 13, 0008
Miami — Outside workers, who face the greatest risk of developing skin cancer from sun exposure, are the least likely to get skin exams, according to a report.
Study shows pollution contributes to male baldness
May 5, 0008
London, England — Male-pattern hair loss can possibly be attributed to air pollution and smoking, according to a study published in the Journal of Investigative Dermatology.
Eating tomatoes could help fight photodamage, study says
May 2, 0008
Manchester, England — A new study suggests consumption of tomato paste may boost the skin’s protection against ultraviolet rays, which can cause premature aging and skin cancer, HealthDay News reports.
Immune drug effective for scalp psoriasis
May 2, 0008
New York — Alefacept, a drug that reduces the activity of certain immune cells, effectively treats scalp psoriasis, Reuters Health reports.
 More Articles
Industry News
Skinvisible signs licensing agreement for two acne products
May 15, 0008
Las Vegas — Skinvisible, a research and development company focused on dermatology products, has signed a licensing agreement with Embil Pharmaceutical Co. for the right to develop and market two acne products, Earthtimes.org reports.
Graceway Pharmaceuticals, Vivicare team up for patient education
May 12, 0008
Berkeley, Calif. — Vivicare, a direct-to-patient education company, is teaming up with Graceway Pharmaceuticals to provide product marketing services for Aldara (Imiquimod), PharmaLive reports.
Stiefel Laboratories acquires ABR Invent and ABR Development
May 6, 0008
Coral Gables, Fla. — Stiefel Laboratories announces the acquisition of ABR Invent and ABR Development, developers of the dermal filler Atlean, PRNewswire reports.
Aveeno, Skin Cancer Foundation kick off ‘Road to Healthy Skin Tour’
May 5, 0008
Skillman, N.J. — The Skin Cancer Foundation’s "Road to Healthy Skin Tour", sponsored by Aveeno and Rite Aid, will offer free full-body skin cancer screenings across the United States, according to a press release.
 More Articles
Special Report: Skin Cancer
Special Report

In this month’s special report, Dermatology Times looks at skin cancer issues, including the continuing controversy over changes in Medicare reimbursement for Mohs surgery. We also offer countering views on the role of sun exposure in the development of melanoma, and we examine expanding uses for topical imiquimod, the use of pulsed-dye lasers for treating basal cell carcinoma, the effectiveness of photodynamic therapy in treating nonmelanoma cancers, and new therapies taking shape for actinic keratoses.
To read our content, click here.

News
Decoding isotretinoin: Understanding mechanism of action may lead to alternative therapies
Isotretinoin is a potent therapy for treating acne, but the associated side effects and regulatory hurdles leave dermatologists increasingly reluctant to use it.
State of the AAD: Academy to help members fulfill D-MOC requirements
The American Academy of Dermatology (AAD) is working to help members fulfill maintenance of certification requirements, President C. William Hanke, M.D., M.P.H., says.
Botox dispersion: Animal study documents functional weakness in non-injected muscles
Botulinum toxin A injections produce a measurable loss of force in both targeted and nearby nontargeted muscles, according to a recent small study.
Dermatology Times issue
Stay connected to Dermatology Times
Receive new issue alerts, technology bulletins, and conference updates!

ADVERTISEMENT

Drug Shows Long-Term Efficacy for Psoriasis
Derm diagnosis: Ulcerated papule on vertex of the scalp
Physician Suicide Rate Higher Than in General Population
Guidelines for Botulinum Neurotoxin Use Issued
What's new in psoriasis therapy
Third Congress of the World Union of Wound Healing Societies
June 04 - June 08
7th ICATMM and 4th EADO Joint Meeting
June 19 - June 21
17th Congress of the European Academy of Dermatology and Venereology
September 17 - September 21
Cleveland Clinic's Dermatopathology Self-Assessment Workshop
October 04
2008 ASDS Annual Meeting
November 06 - November 09

Modern Medicine logoDermatology Times archives are now available on ModernMedicine.com, a new online resource designed to meet the evolving needs of physicians.
Register now (it's free and quick) or Find out more.

Keep visiting DermatologyTimes.com for fresh content, news, opinions, editor's blogs and more.

Click here